SCHEMBL25627288

SCHEMBL25627288

CC(C)(C)c1cc2ccn(CC(C)(C)c3cc4c(F)c[nH]c4nc3F)c2nc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25624105 0.79 — —
SCHEMBL25627483 0.77 CYP1A2 (0.33) —
SCHEMBL25624691 0.75 PDE4B (0.34) —
SCHEMBL25624233 0.68 LRRK2 (0.30) —
SCHEMBL25613023 0.67 ADRA2A (0.31) —
SCHEMBL25624234 0.66 PIM1 (0.32) —
SCHEMBL25624107 0.66 — —
SCHEMBL25626737 0.64 LRRK2 (0.34) —
SCHEMBL25624235 0.64 — —
SCHEMBL25624159 0.62 LRRK2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback